|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7088 | (2006.01) |
| A61K 31/7125 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 7/06 | (2006.01) |
| (11) | Number of the document | 3456333 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18196690.4 |
| Date of filing the European patent application | 2013-11-15 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
| (46) | Date of publication of the claims translation | 2020-06-25 |
| (30) | Number | Date | Country code |
| 201261734941 P | 2012-12-07 | US | |
| 201361799069 P | 2013-03-15 | US | |
| 201313841711 | 2013-03-15 | US | |
| 201361900347 P | 2013-11-05 | US |
| (72) |
STUART, Monic, J., US
KELSEY, Stephen, US
|
| (73) |
Geron Corporation,
919 E. Hillsdale Blvd., Foster City, CA 94404,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Telomerazės inhibitoriaus imetelstato panaudojimas mielodisplastinio sindromo gydymui |
| USE OF THE TELOMERASE INHIBITOR IMETELSTAT FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME |
| Payment date | Validity (years) | Amount | |
| 2024-09-26 | 12 | 289.00 EUR |
| 2025-11-15 |